Find Etravirine manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

API REF. PRICE (USD/KG)

MARKET PLACE

0

FDF

0 DRUGS IN DEVELOPMENT

FDF DossiersDRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

Annual Reports

NA

138 RELATED EXCIPIENT COMPANIES

220EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 269055-15-4, Intelence, Tmc-125, Tmc125, Etravirine (tmc125), Tmc 125
Molecular Formula
C20H15BrN6O
Molecular Weight
435.3  g/mol
InChI Key
PYGWGZALEOIKDF-UHFFFAOYSA-N
FDA UNII
0C50HW4FO1

Etravirine
Etravirine is a diarylpyrimidine non-nucleoside reverse transcriptase inhibitor. Etravirine is designed to be active against HIV isolates with mutations that confer resistance to the two most commonly prescribed first-generation NNRTIs. It can bind the enzyme reverse transcriptase (RT) in multiple conformations, both for native and mutant RT, thereby blocking the enzymatic activity of RT.
Etravirine is a Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor. The mechanism of action of etravirine is as a Non-Nucleoside Reverse Transcriptase Inhibitor, and Cytochrome P450 3A Inducer, and Cytochrome P450 2C9 Inhibitor, and Cytochrome P450 2C19 Inhibitor, and P-Glycoprotein Inhibitor.
1 2D Structure

Etravirine

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
4-[6-amino-5-bromo-2-(4-cyanoanilino)pyrimidin-4-yl]oxy-3,5-dimethylbenzonitrile
2.1.2 InChI
InChI=1S/C20H15BrN6O/c1-11-7-14(10-23)8-12(2)17(11)28-19-16(21)18(24)26-20(27-19)25-15-5-3-13(9-22)4-6-15/h3-8H,1-2H3,(H3,24,25,26,27)
2.1.3 InChI Key
PYGWGZALEOIKDF-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CC1=CC(=CC(=C1OC2=NC(=NC(=C2Br)N)NC3=CC=C(C=C3)C#N)C)C#N
2.2 Other Identifiers
2.2.1 UNII
0C50HW4FO1
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 4-((6-amino-5-bromo-2-((4-cyanophenyl)amino)-4-pyrimidinyl)oxy)-3,5-dimethyl-benzonitrile

2. Benzonitrile, 4-((6-amino-5-bromo-2-((4-cyanophenyl)amino)-4-pyrimidinyl)oxy)-3,5-dimethyl-

3. Intelence

4. R165335

5. Tmc 125

6. Tmc-125

7. Tmc125 Cpd

2.3.2 Depositor-Supplied Synonyms

1. 269055-15-4

2. Intelence

3. Tmc-125

4. Tmc125

5. Etravirine (tmc125)

6. Tmc 125

7. R165335

8. R-165335

9. 4-((6-amino-5-bromo-2-((4-cyanophenyl)amino)pyrimidin-4-yl)oxy)-3,5-dimethylbenzonitrile

10. 4-({6-amino-5-bromo-2-[(4-cyanophenyl)amino]pyrimidin-4-yl}oxy)-3,5-dimethylbenzonitrile

11. 4-[[6-amino-5-bromo-2-[(4-cyanophenyl)amino]-4-pyrimidinyl]oxy]-3,5-dimethylbenzonitrile

12. 0c50hw4fo1

13. Chembl308954

14. Chebi:63589

15. Etravirine-d8

16. 4-((6-amino-5-bromo-2-((4-cyanophenyl)amino)-4-pyrimidinyl)oxy)-3,5-dimethyl-benzonitrile

17. 4-(6-amino-5-bromo-2-(4-cyanoanilino)pyrimidin-4-yloxy)-3,5-dimethylbenzonitrile

18. Benzonitrile, 4-((6-amino-5-bromo-2-((4-cyanophenyl)amino)-4-pyrimidinyl)oxy)-3,5-dimethyl-

19. Benzonitrile, 4-[[6-amino-5-bromo-2-[(4-cyanophenyl)amino]-4-pyrimidinyl]oxy]-3,5-dimethyl-

20. Benzonitrile,4-[[6-amino-5-bromo-2-[(4-cyanophenyl)amino]-4-pyrimidinyl]oxy]-3,5-dimethyl-

21. 65b

22. Intelence(tm)

23. Dapy Deriv

24. 4-(6-amino-5-bromo-2-(4-cyanophenylamino)pyrimidin-4-yloxy)-3,5-dimethylbenzonitrile

25. Intelence (tn)

26. Diaminopyrimidine Deriv

27. Tmc125 Cpd

28. Unii-0c50hw4fo1

29. Etravirine (jan/usan/inn)

30. Etravirine [usan:inn:ban:jan]

31. Etravirine [inn]

32. Etravirine- Bio-x

33. R 165335

34. Etravine; Etravirine

35. 4-[6-amino-5-bromo-2-(4-cyanoanilino)pyrimidin-4-yl]oxy-3,5-dimethylbenzonitrile

36. R165335-tmc125

37. 3m8p

38. Etravirine [mi]

39. Tmc-125/r-165335

40. Etravirine [jan]

41. Etravirine [usan]

42. Etravirine [vandf]

43. Etravirine [mart.]

44. Etravirine [who-dd]

45. Schembl52691

46. Etravirine [ema Epar]

47. Etravirine [orange Book]

48. Dtxsid30181412

49. Hms3651p20

50. Zinc602632

51. Bcp03562

52. Ex-a4282

53. Bdbm50103642

54. S3080

55. 4-({6-amino-5-bromo-2-[(4-

56. Akos015896355

57. Ac-8503

58. Bcp9000006

59. Ccg-269074

60. Cs-0435

61. Db06414

62. He-0088

63. Pb32778

64. 4-[[4-amino-5-bromo-6-(4-cyano-2,6-dimethylphenyloxy)-2-pyrimidinyl]amino]benzonitrile

65. 4-[6-amino-5-bromo-2-(4-cyanoanilino)pyrimidin-4-yl]oxy-3,5-dimethyl-benzonitrile

66. Ncgc00345885-02

67. Ncgc00345885-04

68. Ba164437

69. Hy-90005

70. Bcp0726000193

71. Db-067700

72. Am20080899

73. Cyanophenyl)amino]pyrimidin-4-yl}oxy)-3,5-

74. Ft-0658058

75. Ft-0668442

76. Ft-0668443

77. Sw219570-1

78. A26965

79. D04112

80. Ab01566873_01

81. A818671

82. Q414762

83. Sr-01000944895

84. J-513179

85. Sr-01000944895-1

86. 4-(6-amino-5-bromo-2-(4-cyanophenylamino)pyrimidin-4-ylamino)-3,5-dimethylbenzonitrile

87. 4-[[4-amino 5-bromo-6-(4-cyano-2,6-dimethylphenyloxy)-2-pyrimidinyl]amino]benzonitrile

88. 4-[[4-amino-5-bromo-6-(4-cyano-2,6-dimethylphenyloxy)-2-pyrimidinyl]-amino]benzonitrile

89. 4-[[6-amino-5-bromo-2-(4-cyanoanilino)-4-pyrimidinyl]oxy]-3,5-dimethylbenzonitrile

90. 4-[6-amino-5-bromo-2-(4-cyano-phenylamino)-pyrimidin-4-yloxy]-3,5-dimethyl-benzonitrile

91. 4-((6-amino-5-bromo-2-((4-cyanophenyl) Amino) Pyrimidin-4-yl) Oxy)-3, 5-dimethylbenzonitrile

92. 4-[[6-amino-5-bromo-2-[(4-cyanophenyl)amino]-4-pyrimidinyl]oxy]-3, 5 Cdimethylbenzonitrile

93. 4-[[6-amino-5-bromo-2-[(4-cyanophenyl)amino]-4-pyrimidinyl]oxy]-3,5-dimethyl -benzonitrile

94. 4-[6-azanyl-5-bromanyl-2-[(4-cyanophenyl)amino]pyrimidin-4-yl]oxy-3,5-dimethyl-benzenecarbonitrile

2.4 Create Date
2005-06-24
3 Chemical and Physical Properties
Molecular Weight 435.3 g/mol
Molecular Formula C20H15BrN6O
XLogP34.5
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count7
Rotatable Bond Count4
Exact Mass434.04907 g/mol
Monoisotopic Mass434.04907 g/mol
Topological Polar Surface Area121 Ų
Heavy Atom Count28
Formal Charge0
Complexity609
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Information
1 of 2  
Drug NameIntelence
PubMed HealthEtravirine (By mouth)
Drug ClassesAntiretroviral Agent
Drug LabelINTELENCE (etravirine) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) of human immunodeficiency virus type 1 (HIV-1).The chemical name for etravirine is 4-[[6-amino-5-bromo-2-[(4-cyanophenyl)amino]-4-pyrimidinyl]oxy]-3,5-dimethylbenzon...
Active IngredientEtravirine
Dosage FormTablet
RouteOral
Strength200mg; 25mg; 100mg
Market StatusPrescription
CompanyJanssen R And D

2 of 2  
Drug NameIntelence
PubMed HealthEtravirine (By mouth)
Drug ClassesAntiretroviral Agent
Drug LabelINTELENCE (etravirine) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) of human immunodeficiency virus type 1 (HIV-1).The chemical name for etravirine is 4-[[6-amino-5-bromo-2-[(4-cyanophenyl)amino]-4-pyrimidinyl]oxy]-3,5-dimethylbenzon...
Active IngredientEtravirine
Dosage FormTablet
RouteOral
Strength200mg; 25mg; 100mg
Market StatusPrescription
CompanyJanssen R And D

4.2 Drug Indication

Indicated as an adjunct therapy in the treatment of adult HIV-1 infections resistant to therapy with other NNRTIs and antiretroviral agents.


FDA Label


Intelence, in combination with a boosted protease inhibitor and other antiretroviral medicinal products, is indicated for the treatment of human-immunodeficiency-virus-type-1 (HIV-1) infection in antiretroviral-treatment-experienced adult patients and in antiretroviral-treatment-experienced paediatric patients from six years of age.

This indication is based on week-48 analyses from two phase-III trials in highly pretreated patients where Intelence was investigated in combination with an optimised background regimen (OBR) which included darunavir/ritonavir. The indication in paediatric patients is based on 48-week analyses of a single-arm, phase-II trial in antiretroviral-treatment-experienced paediatric patients.


5 Pharmacology and Biochemistry
5.1 Pharmacology

Clinical trials have shown no prolongation of QT intervals on electrocardiograms after 8 days of dosing.


5.2 MeSH Pharmacological Classification

Reverse Transcriptase Inhibitors

Inhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template. (See all compounds classified as Reverse Transcriptase Inhibitors.)


5.3 FDA Pharmacological Classification
5.3.1 Active Moiety
ETRAVIRINE
5.3.2 FDA UNII
0C50HW4FO1
5.3.3 Pharmacological Classes
Cytochrome P450 2C9 Inhibitors [MoA]; Cytochrome P450 3A Inducers [MoA]; Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Non-Nucleoside Analog [EXT]; Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]; Cytochrome P450 2C19 Inhibitors [MoA]; Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
5.4 ATC Code

J05AG04


J05AG04

S76 | LUXPHARMA | Pharmaceuticals Marketed in Luxembourg | Pharmaceuticals marketed in Luxembourg, as published by d'Gesondheetskeess (CNS, la caisse nationale de sante, www.cns.lu), mapped by name to structures using CompTox by R. Singh et al. (in prep.). List downloaded from https://cns.public.lu/en/legislations/textes-coordonnes/liste-med-comm.html. Dataset DOI:10.5281/zenodo.4587355


J - Antiinfectives for systemic use

J05 - Antivirals for systemic use

J05A - Direct acting antivirals

J05AG - Non-nucleoside reverse transcriptase inhibitors

J05AG04 - Etravirine


5.5 Absorption, Distribution and Excretion

Absorption

Maximum oral absorption is achieved in 2.5-4 hours. Absorption is unaffected by the concomitant use of oral ranitidine or omeprazole, which decrease gastric acidity. Administration under fasting conditions resulted in a near 50% decrease in systemic exposure (AUC) when compared to administration after a meal.


Route of Elimination

After a 800mg dose of radio-labelled etraverine, 93.7% was found to undergo fecal elimination, with 81.2% - 86.4% eliminated unchanged. 1.2% of the dose was renally eliminated, changed. Etravirine is dialyzable (hemodialysis).


Volume of Distribution

Distribution of etravirine into compartments other than plasma has not been evaluated in humans.


Clearance

Renal clearance of etravirine is negligible (<1.2%), thus no dose adjustments are required in patients with renal impairment. Clearance is shown to be reduced in patients with Hepatitis B and/or co-infection, however, the safety profile of etravirine does not call for dosage adjustments.


5.6 Metabolism/Metabolites

Metabolized (in vitro) by the liver CYP450 enzymes: CYP3A4, CYP2C9, CYP2C19. The major metabolites formed by a methyl hydroxylation of the dimethylbenzonitrile moiety retained less than 90% of etravirine's activity.


5.7 Biological Half-Life

Half life of 9.05-41 hours.


5.8 Mechanism of Action

Etravirine exerts its effects via direct inhibition of the reverse transcriptase enzyme of human immunodeficiency virus type 1 (HIV-1). It directly binds reverse transcriptase and consequently blocks DNA-dependent and RNA-dependent polymerase activity. Etravirine does not inhibit human DNA polymerase alpha, beta or gamma.


API Reference Price

read-more
read-more
[{"dataSource":"API Export","activeIngredients":"ETRAVIRINE","year":"2021","qtr":"Q1","strtotime":1611685800,"product":"ETRAVIRINE","address":"1-1-151\/1, SAIRAM TOWERS, 4TH FLOORALEXANDER ROAD","city":"SECUNDERABAD, ANDHRA PRADESH","supplier":"VIATRIS","supplierCountry":"INDIA","foreign_port":"SHEREMETYEVO","customer":"JSC BIOKHIMIK","customerCountry":"RUSSIA","quantity":"1.00","actualQuantity":"1","unit":"KGS","unitRateFc":"4222.3","totalValueFC":"4275","currency":"USD","unitRateINR":312661.63,"date":"27-Jan-2021","totalValueINR":"312661.63","totalValueInUsd":"4275","indian_port":"HYDERABAD AIR","hs_no":"29335990","bill_no":"8168314","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"RUSSIA","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"1-1-151\/1, SAIRAM TOWERS, 4TH FLOORALEXANDER ROAD, SECUNDERABAD, ANDHRA PRADESH","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1642530600,"product":"ETRAVIRINE STANDARD B.NO.EV0111021","address":"882\/1-871, NEAR KANKAVATI ,VILLAGE-","city":"AHMEDABAD, GUJARAT","supplier":"AMNEAL PHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"JOHN F. KENNEDY APT\/","customer":"AMNEAL PHARMACEUTICALS","customerCountry":"UNITED STATES","quantity":"0.01","actualQuantity":"8","unit":"GMS","unitRateFc":"1.4","totalValueFC":"11.1","currency":"USD","unitRateINR":103.625,"date":"19-Jan-2022","totalValueINR":"829","totalValueInUsd":"11.1","indian_port":"Ahmedabad-ZIPL-SEZ","hs_no":"29420090","bill_no":"4000310","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"Ahmedabad-ZIPL-SEZ","supplierAddress":"882\/1-871, NEAR KANKAVATI ,VILLAGE-, AHMEDABAD, GUJARAT","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q4","strtotime":1668105000,"product":"ETRAVIRINE IH","address":"HETERO CORPORATE, NO. 7-2-A2, INDUSTRIAL ESTATE,SANATHNAGAR Conta","city":"HYDERABAD","supplier":"HETERO DRUGS","supplierCountry":"INDIA","foreign_port":"MOSCOW","customer":"TO THE ORDER OF","customerCountry":"RUSSIA","quantity":"2.00","actualQuantity":"2","unit":"KGS","unitRateFc":"2500","totalValueFC":"4876.7","currency":"USD","unitRateINR":199000,"date":"11-Nov-2022","totalValueINR":"398000","totalValueInUsd":"4876.7","indian_port":"HYDERABAD AIR","hs_no":"29269000","bill_no":"5408867","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"RUSSIA","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"HETERO CORPORATE, NO. 7-2-A2, INDUSTRIAL ESTATE,SANATHNAGAR Conta, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1675794600,"product":"ETRAVIRINE IH","address":"HETERO CORPORATE, NO. 7-2-A2, INDUSTRIAL ESTATE,SANATHNAGAR Conta","city":"HYDERABAD","supplier":"HETERO DRUGS","supplierCountry":"INDIA","foreign_port":"SHEREMETYEVO","customer":"TO THE ORDER OF","customerCountry":"RUSSIA","quantity":"2.00","actualQuantity":"2","unit":"KGS","unitRateFc":"2900","totalValueFC":"5606","currency":"USD","unitRateINR":231500,"date":"08-Feb-2023","totalValueINR":"463000","totalValueInUsd":"5606","indian_port":"HYDERABAD AIR","hs_no":"29269000","bill_no":"7640105","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"RUSSIA","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"HETERO CORPORATE, NO. 7-2-A2, INDUSTRIAL ESTATE,SANATHNAGAR Conta, HYDERABAD","customerAddress":""},{"dataSource":"API Import","activeIngredients":"ETRAVIRINE","year":"2021","qtr":"Q1","strtotime":1616697000,"product":"(N.C.V) ETRAVIRINE 250MG\/G SPRAY DRIED POWDER (FOR TESTING PURPOSE ONLY)","address":"30 FORJETT STREETPOST BOX NO 9301","city":"MUMBAI, MAHARASHTRA.","supplier":"JOHNSON & JOHNSON","supplierCountry":"BELGIUM","foreign_port":"","customer":"JOHNSON & JOHNSON","customerCountry":"INDIA","quantity":"5.05","actualQuantity":"5045.14","unit":"GMS","unitRateFc":"3.8","totalValueFC":"23406.1","currency":"EUR","unitRateINR":"337.8","date":"26-Mar-2021","totalValueINR":"1703998.05","totalValueInUsd":"23406.1","indian_port":"BOMBAY AIR","hs_no":"29339990","bill_no":"3311677","productDescription":"API","marketType":"REGULATED MARKET","country":"BELGIUM","selfForZScoreResived":"Pharma Grade","supplierPort":"","supplierAddress":"","customerAddress":"30 FORJETT STREETPOST BOX NO 9301"},{"dataSource":"API Import","activeIngredients":"ETRAVIRINE","year":"2021","qtr":"Q1","strtotime":1617042600,"product":"ETRAVIRINE (QTY: 1 X 0.35 GMS, PRICE: USD-30.65)(FOC)","address":"106, FIRST FLOOR , ASHOKA BHOOPALCHAMBERS BEGUMPET, S.P. ROAD,","city":"HYDERABAD-A.P.","supplier":"THE U.S. PHARMACOPEIAL ","supplierCountry":"INDIA","foreign_port":"","customer":"UNITED STATES PHARMACOPEIA ","customerCountry":"INDIA","quantity":"0.00","actualQuantity":"0.00035","unit":"KGS","unitRateFc":"87571.4","totalValueFC":"31.5","currency":"USD","unitRateINR":"6549057.1","date":"30-Mar-2021","totalValueINR":"2292.17","totalValueInUsd":"31.5","indian_port":"HYDERABAD AIR","hs_no":"29335990","bill_no":"3351632","productDescription":"Re-Import","marketType":"REGULATED MARKET","country":"INDIA","selfForZScoreResived":"Pharma Grade","supplierPort":"","supplierAddress":"","customerAddress":"106, FIRST FLOOR , ASHOKA BHOOPALCHAMBERS BEGUMPET, S.P. ROAD,"},{"dataSource":"API Import","activeIngredients":"ETRAVIRINE","year":"2021","qtr":"Q2","strtotime":1620412200,"product":"(N.C.V) ETRAVIRINE 222MG API PER G SOD POSTDRIED (FOR TESTING PURPOSE ONLY)","address":"30 FORJETT STREETPOST BOX NO 9301","city":"MUMBAI, MAHARASHTRA.","supplier":"JOHNSON & JOHNSON","supplierCountry":"BELGIUM","foreign_port":"BRUSSELS","customer":"JOHNSON & JOHNSON","customerCountry":"INDIA","quantity":"3.13","actualQuantity":"3127.86","unit":"GMS","unitRateFc":"2.5","totalValueFC":"9557.5","currency":"EUR","unitRateINR":"223.8","date":"08-May-2021","totalValueINR":"700077.34","totalValueInUsd":"9557.5","indian_port":"BOMBAY AIR","hs_no":"29339990","bill_no":"3867687","productDescription":"API","marketType":"REGULATED MARKET","country":"BELGIUM","selfForZScoreResived":"Pharma Grade","supplierPort":"BRUSSELS","supplierAddress":"","customerAddress":"30 FORJETT STREETPOST BOX NO 9301"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q2","strtotime":1652812200,"product":"(N.C.V) ETRAVIRINE (FOR TESTING PURPOSE ONLY)","address":"L.B.S. MARG,,MULUND-WEST","city":"MUMBAI,MAHARASHTRA","supplier":"JOHNSON & JOHNSON","supplierCountry":"BELGIUM","foreign_port":"NA","customer":"JOHNSON & JOHNSON","customerCountry":"INDIA","quantity":"0.20","actualQuantity":"195.58","unit":"GMS","unitRateFc":"5","totalValueFC":"1043.2","currency":"EUR","unitRateINR":"412.3","date":"18-May-2022","totalValueINR":"80627.85","totalValueInUsd":"1043.2","indian_port":"BOMBAY AIR","hs_no":"29339990","bill_no":"8731653","productDescription":"API","marketType":"REGULATED MARKET","country":"BELGIUM","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"L.B.S. MARG,,MULUND-WEST"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1657218600,"product":"(N.C.V)ETRAVIRINE 222MG\/G SPRAY DRIED POWDER (FOR TESTING PURPOSE ONLY)","address":"L.B.S. MARG,,MULUND-WEST","city":"MUMBAI,MAHARASHTRA","supplier":"JOHNSON & JOHNSON","supplierCountry":"BELGIUM","foreign_port":"NA","customer":"JOHNSON & JOHNSON","customerCountry":"INDIA","quantity":"0.49","actualQuantity":"485.87","unit":"GMS","unitRateFc":"2.5","totalValueFC":"1244.9","currency":"EUR","unitRateINR":"203.7","date":"08-Jul-2022","totalValueINR":"98987.47","totalValueInUsd":"1244.9","indian_port":"BOMBAY AIR","hs_no":"29335990","bill_no":"9468447","productDescription":"API","marketType":"REGULATED MARKET","country":"BELGIUM","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"L.B.S. MARG,,MULUND-WEST"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1657218600,"product":"(N.C.V)ETRAVIRINE 222MG\/G SPRAY DRIED POWDER (FOR TESTING PURPOSE ONLY)","address":"L.B.S. MARG,,MULUND-WEST","city":"MUMBAI,MAHARASHTRA","supplier":"JOHNSON & JOHNSON","supplierCountry":"BELGIUM","foreign_port":"NA","customer":"JOHNSON & JOHNSON","customerCountry":"INDIA","quantity":"0.49","actualQuantity":"488.52","unit":"GMS","unitRateFc":"2.5","totalValueFC":"1251.7","currency":"EUR","unitRateINR":"203.7","date":"08-Jul-2022","totalValueINR":"99527.2","totalValueInUsd":"1251.7","indian_port":"BOMBAY AIR","hs_no":"29335990","bill_no":"9468447","productDescription":"API","marketType":"REGULATED MARKET","country":"BELGIUM","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"L.B.S. MARG,,MULUND-WEST"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1676831400,"product":"(N.C.V) ETRAVIRINE 250MG\/G SPRAY DRIED POWDER (FOR TESTING PURPOSE ONLY)","address":"L.B.S. MARG,,MULUND-WEST","city":"MUMBAI,MAHARASHTRA","supplier":"JOHNSON & JOHNSON","supplierCountry":"BELGIUM","foreign_port":"NA","customer":"JOHNSON & JOHNSON","customerCountry":"INDIA","quantity":"3.20","actualQuantity":"3200","unit":"GMS","unitRateFc":"3.8","totalValueFC":"13354.2","currency":"EUR","unitRateINR":"344.7","date":"20-Feb-2023","totalValueINR":"1102927.2","totalValueInUsd":"13354.2","indian_port":"BOMBAY AIR","hs_no":"29335990","bill_no":"4719034","productDescription":"API","marketType":"REGULATED MARKET","country":"BELGIUM","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"L.B.S. MARG,,MULUND-WEST"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1693506600,"product":"(N.C.V) ETRAVIRINE (FOR TESTING PURPOSE ONLY)","address":"30 FORJETT STREET","city":"MUMBAI, MAHARASHTRA.","supplier":"JOHNSON & JOHNSON","supplierCountry":"BELGIUM","foreign_port":"BRUSSELS","customer":"JOHNSON & JOHNSON","customerCountry":"INDIA","quantity":"0.01","actualQuantity":"8.17","unit":"GMS","unitRateFc":"5","totalValueFC":"45.1","currency":"EUR","unitRateINR":"459.3","date":"01-Sep-2023","totalValueINR":"3752.07","totalValueInUsd":"45.1","indian_port":"Bombay Air","hs_no":"29335990","bill_no":"7625965","productDescription":"API","marketType":"REGULATED MARKET","country":"BELGIUM","selfForZScoreResived":"Pharma Grade","supplierPort":"BRUSSELS","supplierAddress":"TURNHOUTSEWEG 30 B-2340 Beerse, , BelgiumSDNF Belgium","customerAddress":"30 FORJETT STREET"}]
27-Jan-2021
01-Sep-2023
KGS
overview
Loading...

Average Price (USD/KGS)

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

DRUG PRODUCT COMPOSITIONS

Do you need Business Intel? Ask us

DOSAGE - TABLET;ORAL - 100MG

USFDA APPLICATION NUMBER - 22187

read-more

DOSAGE - TABLET;ORAL - 200MG

USFDA APPLICATION NUMBER - 22187

read-more

DOSAGE - TABLET;ORAL - 25MG

USFDA APPLICATION NUMBER - 22187

read-more

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Fillers, Diluents & Binders

read-more
read-more

Coating Systems & Additives

read-more
read-more

Controlled & Modified Release

read-more
read-more

Direct Compression

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Granulation

read-more
read-more

Lubricants & Glidants

read-more
read-more

Co-Processed Excipients

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Empty Capsules

read-more
read-more

Emulsifying Agents

read-more
read-more

Vegetarian Capsules

read-more
read-more

Taste Masking

read-more
read-more

API Stability Enhancers

read-more
read-more

Rheology Modifiers

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Coloring Agents

read-more
read-more

Parenteral

read-more
read-more

Solubilizers

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty